Exploring the Role of Consciousness in Non-Ordinary States with Chuck Raison
Blind Spots: Exploring What We Cannot See
Release Date: 02/09/2024
Frog and Toad Do Ketamine
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas sits down with longtime friend Andrew Isham to explore his first ketamine-assisted psychotherapy intensive at Integrata. Together, they unpack the preparation, the unusual choice to share the journey with a close friend, and how the medicine compared to Andrew’s past experiences with psilocybin and meditation. The conversation moves from levity and curiosity to profound realizations about agency, intimacy, and embodiment, offering listeners a rare inside view of what ketamine therapy can reveal. (00:33) Setting the Stage — Andrew shares why he chose ketamine therapy....
info_outline
Tuning in to Psychedelic Therapy with Eric Sienknecht
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas talks with psychologist Eric Sienknecht, co-founder of Polaris Insight Center, about the healing synergy of music and psychedelics. They explore sensitivity, attunement, resonance, and the therapeutic possibilities of non-ordinary states, while reflecting on the ethical challenges of music choice in psychedelic therapy. A lyrical, thoughtful conversation on how music can help us remember and reclaim forgotten parts of ourselves. (00:34) Eric’s Early Work: From trauma with first responders to ketamine psychotherapy (03:55) The Entropic Brain: How psychedelics...
info_outline
Cultivating Joy through Ketamine with Jayne Gumpel
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas speaks with Jayne Gumpel about her journey into psychedelic therapy and her work leading ketamine-assisted retreats. They explore the power of group dynamics, the importance of integration, and how ketamine enhances mindfulness and healing. Jayne shares her innovative approach to creating spaces for connection, joy, and personal growth. (00:07) Introduction to Jayne Gumpel and Her Work (11:39) Retreats for Healing: Philosophy and Structure (20:31) Group Dynamics and Connection in Retreats (32:01) Challenges of Post-Retreat Integration (49:08) Ketamine and...
info_outline
After the Storm: Why MDMA Assisted Therapy Still Matters
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas and Dr. Evan Sola discuss the implications of the FDA's decision not to approve MDMA for PTSD treatment, emphasizing the nuances of the MDMA-assisted therapy model. They highlight ongoing clinical trials, including those at the Portland VA and UCLA, and the importance of accurate public and therapist education. Dr. Sola shares his experience with severe PTSD patients and the relational aspects of therapy, stressing the need for humility and supervision. They address misconceptions about the model, advocating for a non-pathologizing, participant-led approach that values the...
info_outline
Expanding Access to (Psychedelic) Care
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas chats with Ronica Mukerjee, DNP, MsA, FNP-BC, PMHNP-BC, LAc, a family and psychiatric nurse practitioner and acupuncturist, discusses her multifaceted work, including holistic psychiatry, gender-affirming care, and psychedelic-assisted treatment. She highlights her work with refugees, particularly Haitians, and her efforts to establish a free trans care program. Ronica shares her experiences in Tijuana during COVID-19, providing medical care in a chaotic environment. She emphasizes the need for inclusive, culturally sensitive approaches to mental health and...
info_outline
Therapy Unblinded: Inside MDMA Research Part 2
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas and Dr. Ingmar Gorman discuss the safety and ethical considerations of , including standardization, non-directive approach, and adherence to therapy protocol. They also explore complex power dynamics in therapeutic relationships, ethical nuances of supporting participants in psychedelic studies, and the importance of representing a diverse population in psychedelic trials. (00:00:00) Introduction (00:10:30) Therapist-participant relationships in psychedelic-assisted therapy trial. (00:14:58) Challenges in supporting participants in psychedelic studies after the end...
info_outline
Therapy Unblinded: Inside MDMA Research
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas talks to Dr. Ingmar Gorman about concerns and methodological critiques of MDMA-assisted therapy, including historical boundary violations and inappropriate treatment of participants. They also address adverse event management, inner healing intelligence, and the importance of adapting language and approach to resonate with each individual participant. Additionally, they discuss the ethical complexities of conducting clinical trials, including balancing participant privacy and safety with the need to share information for public advocacy and education. Finally, they delve...
info_outline
"Setting the Stage" for Psychedelic Therapy with Chris Stauffer
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas talks to Dr. Chris Stauffer about his unique path to becoming a provider of psychedelic therapy, which began in the theater. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: Integrata: Dr. Chris Stauffer, MD, Director of SNaP Lab: Dr. Stauffer (he/they) is Associate Professor of Psychiatry at Oregon Health & Science University (OHSU) and dual board-certified in Psychiatry and Addiction Medicine. Dr. Stauffer is an OHSU medical school alum and completed Adult Psychiatry Residency and an Advanced Neuroscience Research Fellowship at the...
info_outline
The Non-Ordinary States of IFS with Nick Brüss
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas and Nick Brüss chat about the common aims and integration of internal family systems therapy (IFS) and psychedelic-assisted therapy. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: Integrata: Nicholas Brüss, EdD, LMFT:
info_outline
Discussing Psychedelics in Recovery with Kevin Franciotti
Blind Spots: Exploring What We Cannot See
Dr. Chantelle Thomas and Kevin Franciotti have a wide ranging conversation about new opportunities, risks, and political implications of using psychedelics in recovery. Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: Integrata: Kevin Franciotti:
info_outlineDr. Chantelle Thomas has a wide-ranging conversation with Dr. Chuck Raison about how consciousness plays a role in psychedelic-assisted therapies.
Dr. Chuck Raison, M.D., Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families in the School of Human Ecology and a Professor in the Department of Psychiatry at the University of Wisconsin – Madison:
https://www.psychiatry.wisc.edu/staff/raison-charles/
Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: